340 related articles for article (PubMed ID: 2778033)
1. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
[TBL] [Abstract][Full Text] [Related]
2. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.
Clemmons DR; Snyder DK; Williams R; Underwood LE
J Clin Endocrinol Metab; 1987 May; 64(5):878-83. PubMed ID: 3558728
[TBL] [Abstract][Full Text] [Related]
4. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent.
Snyder DK; Underwood LE; Clemmons DR
Am J Clin Nutr; 1990 Sep; 52(3):431-7. PubMed ID: 2203249
[TBL] [Abstract][Full Text] [Related]
5. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
6. Persistent lipolytic effect of exogenous growth hormone during caloric restriction.
Snyder DK; Underwood LE; Clemmons DR
Am J Med; 1995 Feb; 98(2):129-34. PubMed ID: 7847429
[TBL] [Abstract][Full Text] [Related]
7. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
Clemmons DR; Smith-Banks A; Underwood LE
J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
[TBL] [Abstract][Full Text] [Related]
8. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
[TBL] [Abstract][Full Text] [Related]
10. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
11. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.
Ellis KJ; Lee PD; Pivarnik JM; Bukar JG; Gesundheit N
J Clin Endocrinol Metab; 1996 Aug; 81(8):3033-8. PubMed ID: 8768870
[TBL] [Abstract][Full Text] [Related]
12. Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats.
Thissen JP; Triest S; Underwood LE; Maes M; Ketelslegers JM
Endocrinology; 1990 Feb; 126(2):908-13. PubMed ID: 2298175
[TBL] [Abstract][Full Text] [Related]
13. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
14. Long-term weight maintenance and cardiovascular risk factors are not different following weight loss on carbohydrate-restricted diets high in either monounsaturated fat or protein in obese hyperinsulinaemic men and women.
Keogh JB; Luscombe-Marsh ND; Noakes M; Wittert GA; Clifton PM
Br J Nutr; 2007 Feb; 97(2):405-10. PubMed ID: 17298712
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
Young SC; Underwood LE; Celniker A; Clemmons DR
J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
[TBL] [Abstract][Full Text] [Related]
16. Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial.
Sevette A; Smith RC; Aslani A; Kee AJ; Hansen R; Barratt SM; Baxter RC
Clin Nutr; 2005 Dec; 24(6):943-55. PubMed ID: 16083996
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables.
Busby WH; Snyder DK; Clemmons DR
J Clin Endocrinol Metab; 1988 Dec; 67(6):1225-30. PubMed ID: 2461386
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
Kupfer SR; Underwood LE; Baxter RC; Clemmons DR
J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
[TBL] [Abstract][Full Text] [Related]
19. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
[TBL] [Abstract][Full Text] [Related]
20. Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women.
Thompson JL; Butterfield GE; Gylfadottir UK; Yesavage J; Marcus R; Hintz RL; Pearman A; Hoffman AR
J Clin Endocrinol Metab; 1998 May; 83(5):1477-84. PubMed ID: 9589642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
